Glaxo cervical cancer vaccine hit by U.S. delay
Monday, December 17, 2007
|
EU watchdog backs Glaxo breast cancer pill
Friday, December 14, 2007
|
Amgen study shows romiplostim boosts platelets
Monday, December 10, 2007
|
Cephalon's Treanda works in type of leukemia: study
Monday, December 10, 2007
|
U.S. panel rejects Avastin for treating breast cancer
Thursday, December 06, 2007
|
Avastin panel tops make-or-break period for Roche
Friday, November 30, 2007
Roche Holding AG's richly-valued stock could take a significant hit next week if a U.S. regulatory...
|
Many gene tests a waste of money, experts say
Friday, November 30, 2007
Genetic tests to assess disease risk are proliferating but many are a waste of money and tell people...
|
Bristol ends cancer drug deal with Pierre Fabre
Friday, November 23, 2007
Bristol-Myers Squibb Co has ended its license agreement with Pierre Fabre Medicament over an...
|
U.S. groups revise guidelines on anemia drugs
Tuesday, October 23, 2007
Anemia drugs sold by Amgen Inc and Johnson & Johnson should not be given to cancer patients who are...
|
FDA approves Bristol-Myers breast cancer drug
Wednesday, October 17, 2007
A new chemotherapy drug called Ixempra made by Bristol-Myers Squibb Co for women with advanced...
|
Bristol breast cancer drug aims at sickest women
Tuesday, October 16, 2007
A new type of treatment for advanced breast cancer could win U.S. approval this week and offer an...
|
Jury cuts some Wyeth damages, to deliberate more
Monday, October 15, 2007
A Nevada jury cut by about $100 million a compensatory damage award against Wyeth in a trial...
|
Glaxo inks deal for Synta cancer drug
Wednesday, October 10, 2007
GlaxoSmithKline Plc has licensed Synta Pharmaceuticals Corp's experimental drug for advanced...
|
Gene test backs focused use of Amgen's Vectibix
Tuesday, September 25, 2007
New research showing Amgen Inc's colon cancer drug Vectibix only benefits a sub-group of patients...
|
Lilly gets FDA nod on new osteoporosis drug use
Friday, September 14, 2007
Eli Lilly & Co said Friday that it had won approval to market its blockbuster osteoporosis drug to...
|
FDA panel to review Avastin for breast cancer
Friday, September 14, 2007
Genentech Inc.'s blockbuster drug Avastin will be reviewed as a first-line treatment for metastatic...
|
ImClone's Erbitux extends survival in lung cancer
Tuesday, September 11, 2007
The cancer drug Erbitux unexpectedly extended survival in a trial of patients with advanced lung...
|
Antisoma shares leap on positive lung cancer data
Wednesday, August 22, 2007
An experimental drug from Britain's Antisoma Plc and Swiss-based Novartis AG has shown promising...
|
Amedisys to buy IntegriCare home health, hospice assets
Monday, August 06, 2007
Home-healthcare provider Amedisys Inc. said it agreed to acquire the home health and hospice assets...
|
US panel backs Lilly drug for cancer prevention
Tuesday, July 24, 2007
Eli Lilly and Co.'s osteoporosis drug Evista should be approved for reducing the risk of breast...
|
FDA approves J&J test for breast cancer spread
Tuesday, July 17, 2007
A Johnson & Johnson test to detect if breast cancer has spread to a patient's lymph nodes won...
|
New test pinpoints deadliest prostate cancers
Monday, July 16, 2007
Scientists have found a new way to identify a particularly deadly form of prostate cancer in a...
|
Antisoma, Novartis drug fails in ovarian cancer
Thursday, July 12, 2007
An experimental cancer drug from Britain's Antisoma Plc and Swiss-based Novartis AG has failed in a...
|
Genentech profit up 41 percent on Rituxan, Avastin
Thursday, July 12, 2007
Genentech Inc. said on Wednesday that second-quarter profit rose 41 percent, fueled by growth from...
|
ImClone says Erbitux fails in lung cancer trial
Thursday, July 12, 2007
ImClone Systems Inc. said on Thursday its cancer drug Erbitux did not help stave off the disease in...
|
Bristol drug active in metastatic breast cancer
Friday, July 06, 2007
Bristol-Myers Squibb Co. on Friday said its ixabepilone drug demonstrated clear activity in patients...
|
Erbitux gains favor among some oncologists: poll
Friday, June 08, 2007
Doctors are willing to try ImClone Systems Inc.'s Erbitux treatment for colon cancer even after a...
|
Cancer drug news underwhelming for Glaxo and Roche
Monday, June 04, 2007
Clinical trial results released at the weekend for key cancer drugs from GlaxoSmithKline Plc and...
|
Gardasil beats expectations in Europe: executive
Thursday, May 31, 2007
Sales of cervical cancer vaccine Gardasil in Europe have exceeded internal expectations, the head of...
|
Rituxan shows promise in multiple sclerosis trial
Tuesday, May 01, 2007
Genentech Inc. and Biogen Idec Inc. said on Tuesday their blockbuster Rituxan drug for lymph cancer...
|
Smoking stubbed out in Northern Ireland
Monday, April 30, 2007
Smokers in Northern Ireland risk a 50 pound fine if they light up in pubs, offices and other indoor...
|
Spending on biotech drug prescriptions rising
Wednesday, April 25, 2007
Biotech drugs will comprise a quarter of all spending on prescription drugs in five years, driven by...
|
Mouth rinse spots early head and neck cancer
Tuesday, April 24, 2007
Detecting head and neck cancer early, when the odds of successful treatment are best, may be as...
|
Roche raises outlook as cancer and flu drugs gain
Wednesday, April 18, 2007
Swiss drugmaker Roche Holding AG's first-quarter sales jumped 16 percent to 11.4 billion Swiss...
|
Antigenics vaccine shows promise in brain cancer
Monday, April 16, 2007
An Antigenics Inc. cancer vaccine, Oncophage, which failed last year to stave off the recurrence of...
|
Genes gang up to help cancer spread, study finds
Wednesday, April 11, 2007
Four genes gang up together to help cancer spread throughout the body, researchers said on...
|
US tells firms to stop selling some nausea drugs
Friday, April 06, 2007
Companies must stop selling suppositories that contain the ingredient trimethobenzamide to relieve...
|
U.S. company formed for individualized cancer care
Wednesday, March 28, 2007
George Mason University researchers announced on Tuesday the formation of a company to tailor cancer...
|
Amgen cancels Vectibix trial, cites safety
Friday, March 23, 2007
Amgen Inc. said on Thursday it discontinued a key clinical trial of colon cancer treatment Vectibix...
|
US FDA clears Glaxo pill for breast cancer
Tuesday, March 13, 2007
U.S. health regulators have approved GlaxoSmithKline Plc's pill Tykerb for patients with advanced...
|
Glaxo set for big push into cancer medicine
Monday, February 26, 2007
GlaxoSmithKline Plc is preparing for a "renaissance" of its oncology business, led by Tykerb, a...
|
Roche suspends enrollment in anemia drug trial
Friday, February 23, 2007
Swiss drugmakerRoche Holding AG said on Friday it has suspended enrollment in a clinical trial of...
|
Merck ends lobbying for mandatory Gardasil vaccine
Wednesday, February 21, 2007
Drugmaker Merck & Co. said on Tuesday it would stop lobbying state legislatures to make it mandatory...
|
UK mothers back cervical cancer vaccine for kids
Wednesday, January 24, 2007
Three-quarters of mothers in Britain want their young daughters to be vaccinated against a sexually...
|
Good results reported for S-1 gastric cancer drug
Friday, January 19, 2007
Sanofi-Aventis and Taiho Pharmaceutical said final-stage clinical study results of their S-1 oral...
|
Cancer drug attacks tumours in novel way
Wednesday, December 20, 2006
Scientists said on Wednesday they were developing new experimental drugs that block the blood supply...
|
British drug watchdog backs new breast cancer drugs
Wednesday, November 22, 2006
Britain's medicines cost-effectiveness watchdog NICE on Wednesday approved a new class of drugs...
|
Roche to check Herceptin vials after cracks found
Wednesday, November 22, 2006
The European Medicines Agency (EMA) said on Wednesday drugmaker Roche had agreed to inspect vials of...
|
J&J breast cancer test should be approved: US panel
Friday, November 17, 2006
Veridex LLC's lab test to detect breast cancer that has spread to lymph nodes should be approved...
|
